Nuvalent | Investor Presentation Deck | 52 slides · page 19 of 52
The chart displays dose-dependent exposure over 24 hours, with horizontal dashed lines representing efficacy targets for different ROS1 variants in CNS and periphery.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 disclaimer 1/1 list 1/1 title 1/1
Components 4
line disclaimer bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.